A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis
Clinical trial NCT00448383 · COMPLETED
Trial details
- NCT number
- NCT00448383
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2004-11-01
- Enrollment
- 6610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.